Coloplast

Coloplast, a medical, precision and optical instruments, watches and clocks company headquartered in Denmark, reported total carbon emissions of 223,305,000 kg CO2e in 2024. This includes 17,514,000 kg CO2e from Scope 1, 83,000 kg CO2e from Scope 2 (market-based), and 205,708,000 kg CO2e from Scope 3 emissions. In comparison, their 2023 emissions were 219,118,000 kg CO2e, comprising 21,282,000 kg CO2e (Scope 1), 32,170,000 kg CO2e (Scope 2, location-based), and 197,836,000 kg CO2e (Scope 3).

Coloplast has set ambitious, SBTi-validated climate commitments. The company aims for a 100% reduction in absolute Scope 1 and 2 GHG emissions by 2030, using a 2018/19 baseline. They also commit to annually sourcing 100% renewable electricity through 2025. Furthermore, Coloplast targets a 50% reduction in Scope 3 GHG emissions per product manufactured by 2030, also from a 2018/19 base year. Their ambition is to achieve net-zero in Scope 1 and 2, and use 100% renewable energy by 2025. As of 2020/21, Coloplast had already reduced Scope 3 emissions by 10% per product. They also report using 50% less business travel by air than in 2018/19 and aim for 100% electric company cars by 2030.